Cefprozil

Cefprozil
Cefprozil
Systematic (IUPAC) name
7-[2-amino-2-(4-hydroxyphenyl)-acetyl]amino-8-oxo-3-prop-1-enyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Clinical data
Trade names Cefzil
AHFS/Drugs.com monograph
MedlinePlus a698022
Licence data US FDA:link
Pregnancy cat. B(US)
Legal status -only (US)
Routes Oral
Pharmacokinetic data
Bioavailability 95%
Protein binding 36%
Half-life 1.3 hours
Identifiers
CAS number 92665-29-7 YesY
ATC code J01DC10
PubChem CID 9887643
DrugBank APRD00461
ChemSpider 8063315 YesY
UNII 1M698F4H4E YesY
KEGG D07651 YesY
ChEMBL CHEMBL1742 N
Chemical data
Formula C18H19N3O5S 
Mol. mass 389.427 g/mol
SMILES eMolecules & PubChem
 N(what is this?)  (verify)

Cefprozil, sometimes spelled cefproxil and marketed under the trade name Cefzil, is a second-generation cephalosporin type antibiotic. In Europe it is marketed using the trade names Procef and Cronocef.[citation needed] It can be used to treat bronchitis, ear infections, skin infections, and other bacterial infections.[citation needed] It comes as a tablet and as a liquid suspension.

Although there is a widely quoted cross-allergy risk of 10% between cephalosporins and penicillin, an article in the Journal of Family Practice[1] has shown no increased risk for cross-allergy for cefprozil and several other second-generation or later cephalosporins.

References

External links